Trial intelligence / Profile preview

FSH transdermal patch after laser poration versus Fostimon in oocyte donors

2010-020559-29Phase 2Completed

Sponsor
Pantec Biosolutions AG
Start
Jul 2010
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 2, open-label trial of urofollitropin in infertility (2 arms), sponsored by Pantec Biosolutions AG. Primary endpoints: AUC0-t, Cmax and 1 more. Started Jul 2010; status: completed.

02

Drugs

urofollitropin
03

Conditions

infertility

Beyond the preview

Go deeper on 2010-020559-29.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2010-020559-29.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call